| Dennis J Easter, MD | |
|
845 Helen Dr, Lebanon, PA 17042-7493 | |
| (717) 273-8835 | |
| (717) 202-0100 |
| Full Name | Dennis J Easter |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 41 Years |
| Location | 845 Helen Dr, Lebanon, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134115280 | NPI | - | NPPES |
| 001468710 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD040950E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital | Lebanon, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
A burning pain sensation - and treatments that do not work. This is what daily life is like for many of those who suffer from recurrent aphthous stomatitis. Research from the Sahlgrenska Academy now sheds new light on the reasons behind this condition found in the mouth.
The controversy surrounding electronic cigarettes and the FDA continues. As reported by CNN, New York Times and USA Today, the FDA lost its first battle against e-cigarettes in a federal court and is appealing the ruling.
A new brain chemical test that predicts which patients with heart attack symptoms are at higher risk of dying is paradoxically not being used in younger, healthier patients who could benefit the most from the prognostic information provided by this test
Santarus, Inc., a specialty biopharmaceutical company, today announced that is has begun to enroll patients in the first study in its Phase III clinical program to evaluate the efficacy and safety of rifamycin SV MMX® for the treatment of patients with travelers' diarrhea.
› Verified 3 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
A burning pain sensation - and treatments that do not work. This is what daily life is like for many of those who suffer from recurrent aphthous stomatitis. Research from the Sahlgrenska Academy now sheds new light on the reasons behind this condition found in the mouth.
The controversy surrounding electronic cigarettes and the FDA continues. As reported by CNN, New York Times and USA Today, the FDA lost its first battle against e-cigarettes in a federal court and is appealing the ruling.
A new brain chemical test that predicts which patients with heart attack symptoms are at higher risk of dying is paradoxically not being used in younger, healthier patients who could benefit the most from the prognostic information provided by this test
Santarus, Inc., a specialty biopharmaceutical company, today announced that is has begun to enroll patients in the first study in its Phase III clinical program to evaluate the efficacy and safety of rifamycin SV MMX® for the treatment of patients with travelers' diarrhea.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dennis J Easter, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 273-8835 | Dennis J Easter, MD 845 Helen Dr, Lebanon, PA 17042-7493 Ph: (717) 273-8835 |
News Archive
A burning pain sensation - and treatments that do not work. This is what daily life is like for many of those who suffer from recurrent aphthous stomatitis. Research from the Sahlgrenska Academy now sheds new light on the reasons behind this condition found in the mouth.
The controversy surrounding electronic cigarettes and the FDA continues. As reported by CNN, New York Times and USA Today, the FDA lost its first battle against e-cigarettes in a federal court and is appealing the ruling.
A new brain chemical test that predicts which patients with heart attack symptoms are at higher risk of dying is paradoxically not being used in younger, healthier patients who could benefit the most from the prognostic information provided by this test
Santarus, Inc., a specialty biopharmaceutical company, today announced that is has begun to enroll patients in the first study in its Phase III clinical program to evaluate the efficacy and safety of rifamycin SV MMX® for the treatment of patients with travelers' diarrhea.
› Verified 3 days ago
Dr. Daniel P Rollo, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 300 Willow St, Lebanon, PA 17046 Phone: 717-273-8835 Fax: 717-273-0728 | |
Dr. Maryanne T. Mclaughlin, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 845 Helen Dr, Lebanon, PA 17042 Phone: 717-273-8835 Fax: 717-202-0100 | |
Dr. Roger A. Hine, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 845 Helen Dr, Lebanon, PA 17042 Phone: 717-273-8835 Fax: 717-202-0100 | |
Nathan Adam Keller, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 845 Helen Dr, Lebanon, PA 17042 Phone: 717-273-8835 Fax: 717-202-0100 | |
James A Nicholson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 30 N 4th St Fl 2, Lebanon, PA 17046 Phone: 717-274-0474 Fax: 717-270-2374 | |
Dr. Raliat Oluwafunke Bashua, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 845 Helen Dr, Lebanon, PA 17042 Phone: 717-273-8835 Fax: 717-202-0100 |